Key facts
- This page summarizes Chad J. Kolean's Form 4 filing for Cellectar Biosciences, Inc. (CLRB).
- 2 reported transactions and 1 derivative row are listed below.
- Accepted by SEC: 03 Jul 2025, 08:00.
Chad J. Kolean - 02 Jul 2025 Form 4 Insider Report for Cellectar Biosciences, Inc. (CLRB)
- Reporting relationship
- Chief Financial Officer
- Issuer ticker
- CLRB
- Reported as of
- 02 Jul 2025
- Net transaction value
- +$25,000
- SEC form
- 4
- Accepted by SEC
- 03 Jul 2025, 08:00:13 UTC
- Prior SEC filing
- 18 Feb 2025
- Next SEC filing
- 08 Jul 2026
- Source filing
- View source filing
- Reporting owner signature
- /s/ Christina Blakley, attorney-in-fact for Chad J. Kolean
Source evidence
Original filing metadata and source links for verification.
5 source fields
Reporting owner
1 detail
Key filing fact
Chad J. Kolean filed Form 4 for Cellectar Biosciences, Inc. (CLRB) on 03 Jul 2025.
Change
- Previous filing in this sequence was filed on 18 Feb 2025.
- Current net transaction value: +$25,000.
Research use
- This tells you what this filing adds before you inspect full transaction and derivative tables.
- You can trace every row back to the original SEC filing document.
Evidence
Filed on Form 4
View source filing
Ownership activity is grounded in SEC Form 4 disclosures.
Reporting Owners (1)
CIK 0001616753
Primary reporting owner
Kolean Chad J
- Relationship
- Chief Financial Officer
- Address
- C/O CELLECTAR BIOSCIENCES, INC., 100 CAMPUS DRIVE, FLORHAM PARK
- Signature
- /s/ Christina Blakley, attorney-in-fact for Chad J. Kolean
- Signature date
- 03 Jul 2025
Reported non-derivative transactions
Shares, units, or other non-derivative securities reported in this filing.
CLRB
transaction
Common Stock
Purchase
- Transaction value
- $24,950
- Shares
- +5,000
- Change %
- +353%
- Price
- $4.99
- Shares after
- 6,418
- Date
- 02 Jul 2025
- Ownership
- Direct
- Footnotes
- F1
Reported derivative securities
Options, warrants, convertible securities, or similar derivative positions disclosed in the filing.
CLRB
transaction
Derivative
Warrants
Purchase
- Transaction value
- $50
- Shares
- +5,000
- Change %
- Price
- $0.0100
- Shares after
- 5,000
- Date
- 02 Jul 2025
- Ownership
- Direct
- Underlying class
- Common Stock
- Underlying amount
- 5,000
- Exercise price
- $5.25
* marks a reported price that did not pass the local price check.
Additional SEC filing notes
Filing notes and footnotes
Explanation of responses 1 footnote
Footnote F1
This number has been adjusted for the one-for-thirty (1:30) reverse stock split effected by the Issuer on June 24, 2025.